Same day discharge after chronic total occlusion interventions: A single center experience
- PMID: 33048434
- DOI: 10.1002/ccd.29320
Same day discharge after chronic total occlusion interventions: A single center experience
Abstract
Objectives: To assess the feasibility and safety of same day discharge (SDD) after chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
Background: CTO PCI has been associated with higher complication rates and procedural and hospitalization costs. Shortening post-PCI hospitalization length not only increases the patients' comfort but at the same time it consists an important part of cost reduction policies.
Methods: We retrospectively compared the 30-day outcomes of patients who underwent CTO PCI at the Red Cross Hospital, Greece between January 2016 and June 2019 and underwent SDD versus non-SDD. Major adverse cardiovascular events (MACE) were defined as the composite of death, myocardial infarction, urgent repeat target vessel revascularization, tamponade, and stroke.
Results: A total of 173 patients (mean age 63.7 ± 8.9 years) were included, of whom 51 (30%) underwent SDD. SDD patients were less likely to have diabetes mellitus (51 vs. 31%, p = .015), arterial hypertension (89 vs. 67%, p < .001), and acute coronary syndrome presentation (39.7 vs. 21.6%, p = .022), compared with non-SDD patients. Forearm access was used in all SDD patients and in 83% of the non-SDD patients. The 30-day incidence of MACE was 0% in the SDD group and 1.6% in the non-SDD group. Multivariable analysis showed that diabetes mellitus and longer procedural time were associated with lower probability of SDD (OR: 0.34, 95% CI: 0.15, 0.73 and OR: 0.29, 95% CI: 0.12, 0.71, respectively).
Conclusions: SDD appears to be feasible and safe in selected patients undergoing an uncomplicated CTO PCI through forearm approach.
Keywords: chronic total occlusion; complex PCI; health care policy; percutaneous coronary intervention.
© 2020 Wiley Periodicals LLC.
Comment in
-
Everything is outpatient these days: The new economics of sophisticated cardiovascular care.Catheter Cardiovasc Interv. 2021 Dec 1;98(7):1240. doi: 10.1002/ccd.29991. Catheter Cardiovasc Interv. 2021. PMID: 34851017 No abstract available.
References
REFERENCES
-
- Small A, Klinke P, Della Siega A, et al. Day procedure intervention is safe and complication free in higher risk patients undergoing transradial angioplasty and stenting. The discharge study. Catheter Cardiovasc Interv. 2007;70:907-912.
-
- Jabara R, Gadesam R, Pendyala L, et al. Ambulatory discharge after transradial coronary intervention: preliminary US single-center experience (same-day transradial intervention and discharge evaluation, the STRIDE Study). Am Heart J. 2008;156:1141-1146.
-
- Rinfret S, Kennedy WA, Lachaine J, et al. Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen. J Am Coll Cardiol Intv. 2010;3:1011-1019.
-
- Khatri S, Webb JG, Carere RG, et al. Safety and cost benefit of same-day discharge after percutaneous coronary intervention. Am J Cardiol. 2002;90:425-427.
-
- Koutouzis M, Agelaki M, Maniotis C, et al. Predictors of same day discharge after percutaneous coronary interventions. Cardiovasc Revasc Med. 2017;18:241-244.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous